CIRH1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.220600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.405200E-01
Normal-vs-Stage2
2.943000E-01
Normal-vs-Stage3
9.882000E-01
Normal-vs-Stage4
2.543700E-02
Stage1-vs-Stage2
4.115000E-01
Stage1-vs-Stage3
5.753800E-01
Stage1-vs-Stage4
1.780210E-02
Stage2-vs-Stage3
2.237600E-01
Stage2-vs-Stage4
7.449800E-02
Stage3-vs-Stage4
5.365600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.321000E-01
Normal-vs-AfricanAmerican
2.449000E-01
Normal-vs-Asian
3.970400E-01
Caucasian-vs-AfricanAmerican
6.667800E-01
Caucasian-vs-Asian
3.734200E-02
AfricanAmerican-vs-Asian
2.611600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.404800E-01
Normal-vs-Female
2.998200E-01
Male-vs-Female
9.603200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.576200E-01
Normal-vs-Age(41-60Yrs)
1.471800E-01
Normal-vs-Age(61-80Yrs)
4.093800E-01
Normal-vs-Age(81-100Yrs)
7.886200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.718200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.389200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.030200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.909800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.040200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.173400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.661000E-01
Normal-vs-Daily Drinker
6.121000E-01
Normal-vs-Weekly Drinker
3.556000E-01
Normal-vs-Occasional Drinker
4.102300E-02
Normal-vs-Social Drinker
2.646400E-01
Non Drinker-vs-Daily Drinker
9.497000E-01
Non Drinker-vs-Weekly Drinker
4.308600E-01
Non Drinker-vs-Occasional Drinker
2.447800E-02
Non Drinker-vs-Social Drinker
3.548600E-01
Daily Drinker-vs-Weekly Drinker
5.349600E-01
Daily Drinker-vs-Occasional Drinker
6.292100E-02
Daily Drinker-vs-Social Drinker
4.635000E-01
Weekly Drinker-vs-Occasional Drinker
2.544400E-01
Weekly Drinker-vs-Social Drinker
9.466400E-01
Occasional Drinker-vs-Social Drinker
2.388800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.926600E-01
Normal-vs-Grade 2
8.047800E-01
Normal-vs-Grade 3
3.179400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.657740E-03
Grade 1-vs-Grade 3
4.964100E-04
Grade 1-vs-Grade 4
9.926600E-01
Grade 2-vs-Grade 3
1.134050E-01
Grade 2-vs-Grade 4
8.047800E-01
Grade 3-vs-Grade 4
3.179400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.225600E-01
Normal-vs-NonDiabetic
3.043400E-01
Diabetic-vs-NonDiabetic
2.649800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.699800E-01
Normal-vs-NoPancreatitis
3.401200E-01
Pancreatitis-vs-NoPancreatitis
6.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.984000E-01
Normal-vs-N1
3.080200E-01
N0-vs-N1
6.564000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.83219999999795E-05
Normal-vs-TP53-NonMutant
1.768000E-01
TP53-Mutant-vs-TP53-NonMutant
2.09569999998216E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
